Status | Study |
Completed |
Study Name: Nilotinib in the Treatment of Systemic Sclerosis Condition: Systemic Sclerosis Date: 2010-07-01 Interventions: Drug: Nilotinib (Tasigna) Patients will be treated with Nilotinib 400 mg two times a day for 6 months. |
Completed |
Study Name: Angiogenic/Angiostatic Mediators in Patients With Systemic Sclerosis Condition: Systemic Sclerosis Date: 2008-04-25 |
Completed |
Study Name: Stimulatory Autoantibodies to the Platelet-Derived Growth Factor Receptor (PDGFR) in Patients With Systemic Sclerosis Condition: Systemic Sclerosis Date: 2008-04-23 |
Recruiting |
Study Name: Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning for Patients With Severe Systemic Sclerosis Condition: Systemic Scleroderma Severe Systemic Scle Date: 2008-02-22 Interventions: Drug: fludarabine phosphate Gi |
Completed |
Study Name: Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis Condition: Systemic Sclerosis Date: 2007-11-07 Interventions: Drug: Imatinib Mesylate In initial phase, patients will be treated with Gleevec 400 mg daily for 12 mont |
Completed |
Study Name: High Dose Cyclophosphamide for Treatment of Scleroderma Condition: Scleroderma Date: 2007-07-13 Interventions: Drug: IV Cyclophosphamide Cyclophosphamide (50 mg/kg) intravenously daily for 4 consecutive days (total |
Completed |
Study Name: A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma) Condition: Scleroderma, Diffuse Scleroderma, Date: 2007-03-01 Interventions: Drug: Abatacept Active drug, a |
Completed |
Study Name: High Dose Intravenous N-Acetylcysteine Versus Iloprost for Early, Rapidly Progressive Diffuse Systemic Sclerosis Condition: Scleroderma, Diffuse Date: 2007-01-29 Interventions: Drug: N-acetylcysteine (NAC) |
Terminated |
Study Name: Thalidomide for Decreasing Collagen Biosynthesis in People With Progressive Systemic Sclerosis Condition: Scleroderma, Systemic Date: 2007-01-03 Interventions: Drug: Thalidomide Thalidomide |
Completed |
Study Name: Pulmonary Involvement in Scleroderma: A Clinical Study of the Safety and Efficacy of Mycophenolate Mofetil in Scleroderma Patients With Lung Involvement Condition: Scleroderma, Systemic Date: 2006-06-02 Interventions: Drug: Mycophenolate mofetil |